CAY-10603
CAS No. 1045792-66-2
CAY-10603 ( CAY10603 )
Catalog No. M10225 CAS No. 1045792-66-2
A highly potent and selective HDAC6 inhibitor with IC50 of 2 pM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 68 | In Stock |
|
5MG | 87 | In Stock |
|
10MG | 156 | In Stock |
|
25MG | 291 | In Stock |
|
50MG | 492 | In Stock |
|
100MG | 709 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY-10603
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent and selective HDAC6 inhibitor with IC50 of 2 pM.
-
DescriptionA highly potent and selective HDAC6 inhibitor with IC50 of 2 pM; 200-fold less potent for HDAC3 (IC50=0.42 nM) and no inhibition on HDAC1/2/8/10 (IC50> 100 nM); downregulates the levels of EGFR protein and synergizes with gefitinib to induce apoptosis of the lung adenocarcinoma cell lines.
-
SynonymsCAY10603
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC1;HDAC6
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1045792-66-2
-
Formula Weight446.50
-
Molecular FormulaC22H30N4O6
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OC(C)(C)C)NC1=CC=C(C2=CC(C(NCCCCCCC(NO)=O)=O)=NO2)C=C1
-
Chemical NameCarbamic acid, N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-, 1,1-dimethylethyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kozikowski AP, et al. J Med Chem. 2008 Aug 14;51(15):4370-3.
2. Wang Z, et al. Oncol Rep. 2016 Jul;36(1):589-97.
2. Wang Z, et al. Oncol Rep. 2016 Jul;36(1):589-97.
molnova catalog
related products
-
SR-18292
SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
-
LB-205
A Zn2+-dependent pan-inhibitor of class I and class II HDACs with a long half-life (12h) in vivo.
-
TMP-269
A potent and selective class IIa HDAC inhibitor.